Phillips Electronics North America Corp. has recalled 71 HeartStart MRx defibrillators produced in September and October 2016 due to a defect that may cause the device to fail, the Food and Drug Administration announced Friday. If used in automated external defibrillator mode after failing, the device will not delivery patient therapy, which may lead to serious patient injury or death, the agency said. For more information and a list of affected devices, see the FDA notice.

Related News Articles

Webinar Recordings
Member
Learn how a Patient Risk Assessment Profile allowed nurses to proactively assess patient risk to guide staffing decisions and nurse-patient assignment.…
Webinar Recordings
Member
Tuesday, August 6, 2019
Letter
Public
AHA encourages Congressional leaders to pass the Pandemic and All-Hazards Preparedness…
Issue Brief
How are value and health equity connected?
Letter
Public
Download the letter (PDF) below Re: CMS—3346—P, Medicare
Case Studies
In 2001, a Samaritan Health Services (SHS) physician, Dr. Richard Wopat, recognized the need to improve birth outcomes of high-risk pregnant women in the…